Microwave ablation without subsequent lumpectomy versus breast-conserving surgery for early breast cancer: a propensity score matching study

PURPOSE To compare the efficacy of ultrasound-guided percutaneous microwave ablation (MWA) without subsequent lumpectomy and breast-conserving surgery (BCS) in patients with early breast cancer (BC). MATERIALS AND METHODS This retrospective cohort study enrolled 106 patients with early BC (T0/1/2 N0/1 M0) treated by MWA (n = 21) or BCS (n = 85) from October 2014 to December 2020. Propensity score matching (PSM) was performed to balance the baseline characteristics between MWA and BCS groups. The tumor progression, overall survival (OS), disease-specific survival (DSS), complications, and cosmetic results were compared. RESULTS After PSM, there were 21 patients with balanced baseline characteristics in each group. After a median follow-up of 43 months (range, 15-89 months), there was no significant difference in tumor progression (10% vs 2%, p = 0.18), OS (96% vs 99%, p = 0.36), DSS (100% vs 99%, p > 0.99), and complications (0% vs 19%, p = 0.58). The operation time of MWA was shorter (60 min vs 101 min, p < 0.001) than that of BCS. For the management of metastatic lymph nodes, five (5/21, 24%) patients with six metastatic nodes underwent ablation in the MWA group and three patients (3/21, 14%) with six metastatic nodes underwent axillary lymph node dissection in the BCS group. All the patients in the MWA group reported excellent cosmetic results, but 29% of BCS patients expressed dissatisfaction with breast asymmetry (10%) and scar formation (19%) (p < 0.001). CONCLUSION This pilot study indicated that in selected early BC patients, microwave ablation without subsequent lumpectomy had comparable tumor control effect with breast-conserving surgery and better cosmetic results at an intermediate follow-up.HighlightsMWA without subsequent lumpectomy has a comparable interim survival effect and better cosmetic results as BCS in the treatment of selected early breast cancer.MWA has the potential to be a viable and promising therapeutic option for breast cancer patients reluctant or intolerant to surgery with the advantage of minimal invasion.

[1]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[2]  P. Liang,et al.  Microwave Ablation Versus Nipple Sparing Mastectomy for Breast Cancer ≤5 cm: A Pilot Cohort Study , 2020, Frontiers in Oncology.

[3]  E. Mittendorf,et al.  Patient preferences for locoregional therapy in early-stage breast cancer , 2020, Breast Cancer Research and Treatment.

[4]  Rong Wu,et al.  Diagnostic efficacy of contrast-enhanced ultrasound for breast lesions of different sizes: a comparative study with magnetic resonance imaging. , 2020, The British journal of radiology.

[5]  C. Li,et al.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China , 2019, JAMA surgery.

[6]  A. Petit,et al.  Radiofrequency Ablation Followed by Surgical Excision versus Lumpectomy for Early Stage Breast Cancer: A Randomized Phase II Clinical Trial. , 2018, Radiology.

[7]  L. Livi,et al.  The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study , 2018, BioMed Research International.

[8]  W. Tjalma,et al.  Breast reconstruction after breast conservation therapy for breast cancer. , 2018, European journal of obstetrics, gynecology, and reproductive biology.

[9]  P. Nahon,et al.  Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. , 2017, Journal of hepatology.

[10]  L. Koppert,et al.  Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients , 2017, International journal of cancer.

[11]  Thomas G. Walker,et al.  Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice Committee. , 2017, Journal of vascular and interventional radiology : JVIR.

[12]  A. Napoli,et al.  Minimally invasive ablative techniques in the treatment of breast cancer: a systematic review and meta-analysis , 2016, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[13]  Francesco Sardanelli,et al.  Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis , 2017, European Radiology.

[14]  Yanni Jiang,et al.  Image and pathological changes after microwave ablation of breast cancer: a pilot study. , 2014, European journal of radiology.

[15]  V. Brouste,et al.  Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes. , 2012, Radiology.

[16]  Yicheng Ni,et al.  US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. , 2012, Radiology.

[17]  T. Field,et al.  Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer. , 2011, Journal of the American College of Surgeons.

[18]  S. Plevritis,et al.  A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. , 2010, Journal of the National Cancer Institute.

[19]  A. Stubhaug,et al.  Assessment of pain. , 2008, British journal of anaesthesia.

[20]  L. Newman,et al.  Predictors of breast asymmetry after breast-conserving operation for breast cancer. , 2008, Journal of the American College of Surgeons.

[21]  J. Coebergh,et al.  An overview of prognostic factors for long-term survivors of breast cancer , 2007, Breast Cancer Research and Treatment.

[22]  L. Livi,et al.  Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. , 2007, Gynecologic oncology.

[23]  B. Goh,et al.  Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy , 2004, Cancer.

[24]  S. Singletary,et al.  Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma , 2002, CA: a cancer journal for clinicians.